Evidence for families

What the Evidence Really Says — A Summary for Families

The fear that a biopsy will spread cancer stops many families from allowing diagnosis at all. The evidence does not support that fear. This page explains what the research actually shows, in language you can share with an elder who is not yet ready to agree.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Biopsy does not spread cancer — This is what decades of oncology research consistently shows, and it is the position of ASCO, ESMO and NCCN.
Seeding is rare and specific — Needle tract seeding is documented in a small subset of specific cancer types, and technique is designed to minimise it.
The real harm is delay — Cancer diagnosed at a later stage has fewer treatment options. That is the risk the evidence consistently points to.
Your team can explain the specifics — If you have a particular concern about a specific cancer type, ask your oncologist what the evidence shows for that diagnosis.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

The evidence shows biopsies do not cause cancer to spread through the body. Needle tract seeding — where cells are disturbed along the needle path — is documented in very few specific cases and is managed through technique. Refusing a biopsy means refusing a diagnosis, and that delay is what does real harm.

Does a biopsy cause cancer to spread?

The biopsy needle will make the cancer spread.

The evidence does not support this. Studies reviewed by ASCO and ESMO consistently find no meaningful increase in spread from a diagnostic biopsy in the vast majority of cancers. Cancer spreads through its own biology — changes inside the tumour cells over time — not because a needle passed through tissue.

Once you cut into a tumour, cancer escapes into the blood.

Cancer cells do not simply escape because tissue is touched. Spread — what oncologists call metastasis — happens through specific biological processes that are already under way or are not, regardless of the biopsy. The fear is very understandable. The biology does not work this way.

If the tumour is left undisturbed, it will not grow.

A tumour grows on its own timeline, determined by its own cells. Avoiding a biopsy does not slow that growth. What it does change is the information available to your treating team — and that information is what determines which treatment to start and when.

The biopsy will cause the cancer to come back later.

Recurrence is driven by the biology of the original tumour — how aggressive it is, whether cells had already spread before diagnosis. The evidence does not support the idea that a biopsy procedure triggers recurrence. This fear is widely held and not supported by the published research.

We should try natural treatment first and biopsy only if that fails.

There is no way to know whether any treatment is working without first knowing what you are treating. Please tell your oncology team about any other treatments being considered or already started — traditional or otherwise — so that nothing conflicts quietly with the care plan that follows diagnosis.

What do the studies actually show about biopsy safety?

Research across multiple cancer types consistently shows that a diagnostic biopsy does not cause cancer to spread through the body. This is not a matter of dispute among oncologists. ASCO, ESMO and NCCN cite tissue biopsy as the standard route to diagnosis because the evidence supports it.

The concept that does have some basis in evidence is called needle tract seeding — where a very small number of tumour cells are disturbed along the path a needle takes through tissue. This has been documented in a small subset of specific cancers. In those cases, the procedure is specifically planned to minimise it through image guidance and needle route selection.

The evidence also shows that delayed diagnosis does real harm. Cancer found at an earlier stage has more treatment options — sometimes including surgery or targeted therapy that would not remain possible at a later stage. That is the risk the research consistently points to.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What do these medical words actually mean?

Biopsy: A procedure where a small sample of tissue is removed from a suspected tumour — usually through a needle, sometimes through a small cut — and examined under a microscope by a pathologist. It is the only way to know with certainty what type of cells are present. Every treatment decision that follows depends on this result.
Needle tract seeding: The movement of a very small number of tumour cells along the path a biopsy needle travels through tissue. It is rare overall, has been documented in specific cancer types — including some liver and kidney tumours — and is minimised through careful planning of the procedure, including image guidance and the angle of approach.
Pathology report: The written result after a biopsy sample is examined in the laboratory. It names the cancer type, describes how abnormal the cells look, and records other features that guide treatment. Without it, your team cannot determine whether chemotherapy, surgery, targeted therapy or immunotherapy is the appropriate starting point.
Staging: The process of establishing how far a cancer has spread in the body. Staging cannot be done accurately without first knowing what the cancer is — which requires a biopsy. The stage, in turn, determines which treatments are available and what they are intended to achieve.
False negative: A biopsy result that does not find cancer even though cancer is present — usually because the needle sampled tissue adjacent to the tumour rather than within it. Your oncology team weighs biopsy results alongside imaging and clinical findings for exactly this reason. If the result does not match the clinical picture, a repeat biopsy may be recommended.

What should your family know before the appointment?

The fear that a biopsy will spread cancer is one of the most common reasons families delay or refuse diagnosis in India. It is understandable — especially when the belief comes from an elder whose word carries weight in the family. Naming that fear directly, rather than dismissing it, is usually what makes the conversation move.

What delay does is remove options. Cancer found earlier has more choices. Sometimes it means surgery or targeted treatment that would no longer be possible at a later stage. That is the risk the evidence consistently points to, and it is the one worth weighing.

The most useful thing you can take into the appointment is a specific question: ask your oncologist to explain, for this particular suspected cancer, what the biopsy involves and what the evidence says about its safety. A direct answer in the room carries more weight than anything read or heard elsewhere.

If any other treatments have already been started — traditional, homoeopathic or otherwise — tell the team. Some preparations can affect tissue samples or interact with assessments. Your team is not there to judge the choice; they need the information to advise safely.

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

Myths: Does a Biopsy Spread Cancer?

Cost, Insurance & Schemes

Do You Really Need a Biopsy?

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

My father is convinced the biopsy will spread the cancer. How do I explain it to him?

The most effective approach is usually not explanation from a family member but a direct conversation between your father and the oncologist in the clinic. Ask the doctor at the next appointment to address this fear specifically — not in passing, but as the main question for that visit. What often helps is hearing from a treating doctor that cancer spreads through its own biology, not because a needle touched it, and that this is what the evidence across decades of oncology research consistently shows. If your father wants to understand the reasoning rather than simply be reassured, that is a reasonable request to make of the team.

Are there any cancers where biopsy seeding really is a documented risk?

Yes, and knowing this precisely is more useful than a blanket reassurance. Needle tract seeding has been documented in specific scenarios — including certain liver tumours and some kidney cancers — and oncologists take those cases seriously. In those situations, the procedure is planned specifically to minimise the risk: the needle route, the angle through tissue, and image guidance are all chosen with this in mind. This is why oncologists plan biopsies rather than treating them as generic procedures. If you are concerned about seeding for a specific diagnosis, ask your oncologist directly what the evidence shows for that cancer type and what precautions the team takes.

We tried homoeopathic treatment for two months before agreeing to a biopsy. Does that matter?

Tell your oncology team exactly what was taken and for how long. Some preparations can affect tissue samples or interact with assessments, and the team needs to know in order to advise safely — not to judge the decision. The more pressing concern is that two months without a diagnosis is time during which the disease may have progressed, and the stage at which it is found now affects which treatment options remain available. The biopsy will tell the team what they are working with today, and that is the starting point for everything that follows.

How accurate is a biopsy? What if it misses the cancer?

No test is perfectly accurate, and pathology is no different. A biopsy samples a specific area of tissue, and in some cases the needle may not capture the most representative part of the tumour — this is called a false-negative result. Your team is aware of this possibility and weighs the biopsy result alongside imaging, examination findings and clinical judgement. If the result does not match the clinical picture, a repeat biopsy or a different sampling approach may be recommended. This limitation is a reason to have results interpreted by an experienced team, not a reason to avoid the procedure.

How long does it take to get biopsy results, and what happens while we wait?

A standard pathology result typically takes several days to about two weeks, depending on where the sample is sent and what tests are requested. Some tests — including biomarker testing for targeted therapies — take longer. Ask your team when the sample was sent, what tests have been ordered, and by when you should expect a result. If that date passes without news, follow up directly. While waiting, your team may begin other staging investigations so that once the pathology is known, no time is lost moving to a treatment decision.

Full index